Medical Therapy of Cardiogenic Shock: Contemporary Use of Inotropes and Vasopressors
European Journal of Heart Failure · 01.02.2024 · 26 (2) · 411-431
DOI: 10.1002/ejhf.3162 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Heart Failure, online erschienen am 23.02.2024. Verfasst von Mauro Riccardi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of B…. Hauptthemen laut MEDLINE: Heart Failure, Myocardial Infarction. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 195 Literaturangaben.
Abstract (Originalsprache)
Cardiogenic shock is a primary cardiac disorder that results in both clinical and biochemical evidence of tissue hypoperfusion and can lead to multi-organ failure and death depending on its severity. Inadequate cardiac contractility or cardiac power secondary to acute myocardial infarction remains the most frequent cause of cardiogenic shock, although its contribution has declined over the past two decades, compared with other causes. Despite some advances in cardiogenic shock management, this clinical syndrome is still burdened by an extremely high mortality. Its management is based on immediate stabilization of haemodynamic parameters so that further treatment, including mechanical circulatory support and transfer to specialized tertiary care centres, can be accomplished. With these aims, medical therapy, consisting mainly of inotropic drugs and vasopressors, still has a major role. The purpose of this article is to review current evidence on the use of these medications in patients with cardiogenic shock and discuss specific clinical settings with indications to their use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
- Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', Bucharest, Romania.
- Université Paris Cité, Inserm MASCOT, AP-HP Department of Anesthesia and Critical Care, Hôpital Lariboisière, Paris, France.
- Momentum Research Inc, Durham, NC, USA.
- Heart Centre, Department of Cardiology, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
ORCID-Profile: Marco Metra
Zitieren
APA
Riccardi, M., Pagnesi, M., Chioncel, O., Mebazaa, A., Cotter, G., Gustafsson, F., Tomasoni, D., Latronico, N., Adamo, M., & Metra, M. (2024). Medical Therapy of Cardiogenic Shock: Contemporary Use of Inotropes and Vasopressors. European Journal of Heart Failure, 26(2), 411-431. https://doi.org/10.1002/ejhf.3162
Vancouver
Riccardi M, Pagnesi M, Chioncel O, Mebazaa A, Cotter G, Gustafsson F, et al. Medical Therapy of Cardiogenic Shock: Contemporary Use of Inotropes and Vasopressors. European Journal of Heart Failure. 2024;26(2):411-431. doi:10.1002/ejhf.3162
BibTeX
@article{Riccardi2024,
author = {Riccardi, Mauro and Pagnesi, Matteo and Chioncel, Ovidiu and Mebazaa, Alexandre and Cotter, Gad and Gustafsson, Finn and Tomasoni, Daniela and Latronico, Nicola and Adamo, Marianna and Metra, Marco},
title = {Medical Therapy of Cardiogenic Shock: Contemporary Use of Inotropes and Vasopressors},
journal = {European Journal of Heart Failure},
year = {2024},
volume = {26},
number = {2},
pages = {411--431},
doi = {10.1002/ejhf.3162}
}
EUVIMED